INTRODUCTION
============

In China, colorectal cancer (CRC) has become one of the most common malignancies, ranking fifth in males and fourth in females [@b1-cln_71p264]. Although surgical resection is the most effective method for curing CRC, postoperative complications such as anastomotic leakage reportedly lead to poor oncologic outcomes such as local recurrence in CRC patients [@b2-cln_71p264],[@b3-cln_71p264]. Currently, a stapling device is widely used for providing well-established anastomosis, especially for a low anterior resection, as this device can place the purse-string suture on the distal rectum, which is impossible in the hand-sewn procedure [@b4-cln_71p264][@b5-cln_71p264]-[@b6-cln_71p264]. Nevertheless, anastomotic complications, such as anastomotic bleeding, strictures and leakages, still occur postoperatively [@b7-cln_71p264][@b8-cln_71p264]-[@b9-cln_71p264]. Additionally, the localized inflammatory response accounts for the foreign bodies that cross the mucosal barriers and thus evoke potential anastomosis-related morbidity [@b10-cln_71p264],[@b11-cln_71p264].

Recently, new compression devices incorporating nickel-titanium shape memory alloys (NiTi CAR 27) have been applied for end-to-end colorectal anastomosis. Unlike the traditional staplers, NiTi CAR 27 provides sutureless colorectal anastomosis by using compression, which may thus avoid anastomotic complications resulting from inflammatory processes due to the suture equipment [@b11-cln_71p264]. The safety of NiTi CAR 27 has been demonstrated in numerous animal studies [@b12-cln_71p264],[@b13-cln_71p264]. Early clinical research also suggested that NiTi CAR 27 might create a more secure colorectal anastomosis and serve as an effective alternative for anastomotic procedures [@b14-cln_71p264],[@b15-cln_71p264]. To date, the clinical outcome after the application of NiTi CAR™27 on CRC Chinese patients remains unclear. The aim of this single-center study is to evaluate the safety and efficacy of a NiTi CAR 27 device in an end-to-end anastomosis after sigmoidectomy and anterior resection by comparing the complication rates and the long-term postoperative survival data with stapled anastomosis.

METHODS
=======

Patients
--------

In this retrospective study, consecutive patients undergoing sigmoidectomy and anterior resection with NiTi CAR 27 were included from May 2010 to June 2012 at the Cancer Center, Sun Yat-Sen University, Guangzhou, China. The clinical data of CRC in the similar locations resected using stapled anastomosis (STA) were collected during the same period. The inclusion criteria were as follows: age \>18 years, Eastern Cooperative Oncology Group (ECOG) performance status ≤2, pathological diagnosis of adenocarcinoma, and rectum tumor located ≥3 cm above the anal verge. The exclusion criteria were as follows: tumor located on the right side of the colon, sigmoidectomy and an anterior resection performed previously, uncontrolled severe cardiovascular and respiratory system disease, pregnancy, and a history of other active malignancies (except for basal cell carcinoma of the skin) during the previous 3 years. NiTi CAR 27 was applied for the end-to-end anastomosis by a team of surgeons who have been using stapling anastomotic devices for more than 10 years in our department. The pathological stage of the tumor in the resected specimen was classified according to the tumor-node-metastasis (TNM) staging system of the American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) [@b16-cln_71p264]. Prior to the surgical procedure, informed consent was obtained from all of the patients. They were well informed of the method of anastomotic construction by NiTi CAR 27. Study approval was obtained from independent ethics committees at the Cancer Center of Sun Yat-Sen University. The study was undertaken in accordance with the ethical standards of the World Medical Association Declaration of Helsinki.

Evaluation of clinical parameters
---------------------------------

The clinical data on the patient demographics, tumor features, perioperative parameters, and postoperative complications were recorded with an electronic medical record system. The perioperative parameters included the length of the operation time, the perioperative blood loss during the hospital stay, and the time to the first flatus. Clinical anastomotic leakage was diagnosed based on symptoms such as fever, abdominal pain and tenderness. The presence of fecal discharge from the pelvic drain or fecal bubbles surrounding the anastomosis observed in computed tomography scans was also recognized as anastomotic leakage. Anastomotic stricture was well defined as the diameter of the lumen that was smaller than a standard 12-mm diameter colonoscopy. Anastomotic hemorrhage was noted when there was an excess anal blood loss of 50 ml postoperatively.

Description and procedure of using NiTi CAR 27
----------------------------------------------

NiTi CAR 27 is composed of a main body and detachable compression elements ([Figure 1](#f1-cln_71p264){ref-type="fig"}). The compression elements include a plastic anvil ring and a metal ring incorporating a temperature-dependent shape memory nitinol leaf. The leaf springs maintain a continuous pressure at the anastomosis, independent of the thickness of the tissue. When the tissue around the circular edges heals, the compression element falls off of the compressed tissue within the following 8-10 days as the metal ring is expelled from the body by bowel movement [@b17-cln_71p264]. The NiTi CAR 27 was manipulated according to the manufacturer's instructions. Before the procedure, the nitinol metal ring is saturated in ice water for approximately 30 seconds. After the anvil of the NiTi CAR 27 is secured, the bowel is returned to the peritoneal cavity. Then, the firing device is pushed from the anus to the blind end of the corresponding colorectum. Subsequently, the knob is rotated to the left until the pricker of the firing device reaches a proper position and connects with the anvil. The knob is rotated to the right as a click sound is heard. As a result, end-to-end anastomosis is constructed by pushing forward the firing handle and withdrawing the firing device from the intestinal canal. Finally, the completion of the anastomosis is confirmed by an air-leak test. If the leakage test is positive, a diverting ileostomy is performed.

Postoperative follow-up
-----------------------

After discharge from the hospital, all patients were followed up in the first month after the operation and every 3 months for the first 2 years postoperatively. Then, an every 6-month follow-up was conducted until 5 years after the surgical operation. The follow-up data were obtained by mail, telephone correspondence and outpatient department visits. The routine follow-up visits consisted of a physical examination, routine blood tests, chest radiography, abdominal ultrasonography (US), contrast-enhanced computed tomography (CT) scans and a pelvic nuclear magnetic resonance (MRI). An electronic colonoscopy was suggested for all patients at the third month postoperatively.

Statistical analyses
--------------------

The continuous variables are presented as the mean ± standard deviations and were compared using a Mann--Whitney U-test or Fisher\'s exact test. Categorical results were compared using a chi-square test. The Kaplan--Meier method was applied to determine the overall survival (OS). Differences in survival outcomes between the two groups were compared with the log-rank test. All of the tests were two-tailed, in which a *p* value \<0.05 was considered statistically significant. The data were analyzed using Statistical Package for the Social Sciences (SPSS) 17.0 for Windows (SPSS Inc. Chicago, IL, USA).

RESULTS
=======

Clinical characteristics
------------------------

A total of 234 patients received an anterior resection or a sigmoidectomy for colorectal cancer. The clinical pathological characteristics of the patients from the group with anastomosis using NiTi CAR 27 (CAR group, N=77) and the group with the stapling device (STA group, N=157) were compared ([Table 1](#t1-cln_71p264){ref-type="table"}). There was no significant difference in terms of preoperative clinical demographics and tumor features, including age, sex, clinical stage, body mass index (BMI), tumor sites and comorbidities with the exception of severe anemia. Perioperative parameters, including length of operation time, perioperative blood loss, hospital stay and time to first flatus, were also comparative between the two groups ([Table 2](#t2-cln_71p264){ref-type="table"}).

Postoperative complications
---------------------------

The incidence of postoperative complications, such as anastomotic leakage, anastomotic stricture and intestinal obstruction, did not show significant differences between the two groups ([Table 3](#t3-cln_71p264){ref-type="table"}). Detailed information on the six patients who experienced postoperative complications in the CAR group is summarized in [Table 4](#t4-cln_71p264){ref-type="table"}. A clinically apparent anastomotic leakage occurred in 2 patients (2.6%) ([Figure 2](#f2-cln_71p264){ref-type="fig"}). A 46-year-old female undergoing a low anterior resection for rectal cancer (5 cm from the anus) experienced anastomotic leakage on the 4^th^ postoperative day. The other case of leakage was observed in a 61-year-old male who received an anterior resection for rectal cancer (10 cm from the anus) within 5 days after the surgery. A temporary diverting ileostomy was performed for these two patients. Consequently, the symptoms of both patients were relieved after surgery. Anastomotic stricture was diagnosed by an electronic colonoscopy after 3 months in a 65-year-old male (1.3%) receiving an anterior resection ([Figure 3](#f3-cln_71p264){ref-type="fig"}). No treatments were required due to the absence of obvious symptoms. Three patients (3.9%) experienced intestinal obstruction at 6-11 days postoperatively. A 74-year-old man recovered after conservative treatment, whereas the condition of a 20-year-old woman receiving the same treatment worsened because of organ failure as a result of tumor progression. Another 68-year-old male with postoperative obstruction was successfully treated with a reoperation. The NiTi CAR 27 rings were spontaneously evacuated from the stool within 10 to 20 days (median 14 days) after the operation ([Figure 4](#f4-cln_71p264){ref-type="fig"}). The anastomosis was smooth and without metallic foreign material after 3 months when observed using electronic colonoscopy ([Figure 5](#f5-cln_71p264){ref-type="fig"}). No anastomotic hemorrhage or perioperative death occurred in this study.

Long-term outcome
-----------------

With median follow-up duration was 39.6 months. The 3-year overall survival rates in the CAR group and the STA group were 83.1% and 89.0%, respectively (*p*=0.152, [Figure 6A](#f6-cln_71p264){ref-type="fig"}). For the stage I-III patients, the 3-year overall survival rates in the CAR group and the STA group were 94.5% and 98.2%, respectively (*p*=0.205, [Figure 6B](#f6-cln_71p264){ref-type="fig"}). For the stage IV patients, the 3-year overall survival rates in the CAR group and the STA group were 12.1% and 32.3%, respectively (*p*=0.170, [Figure 6C](#f6-cln_71p264){ref-type="fig"}).

DISCUSSION
==========

Nitinol, an advanced metal alloy of nickel and titanium, exhibits "shape memory," which is the ability to return to its original shape after being deformed according to the temperature [@b18-cln_71p264]. NiTi CAR 27, a new device manufactured with this metal alloy, has several advantages over conventional staplers for colorectal anastomosis. First, the nitinol leaf springs adapt to variations in tissue thickness and accommodate the compressed tissue with a constant force around the full circumference of the anastomosis [@b11-cln_71p264]. Without a permanent suture remaining, the use of this device reduces the local long-term inflammatory process of anastomosis. Moreover, the scarring area of the anastomosis is minimal and appears smooth during the healing process [@b19-cln_71p264][@b20-cln_71p264]-[@b21-cln_71p264]. Although the US Food and Drug Administration (FDA) approved NiTi CAR™ 27 for use in intestinal anastomoses in August 2006, clinical experiments using NiTi CAR 27 in colorectal anastomosis are scarce in China. To evaluate the safety and efficacy of using this device for colorectal cancer surgery, we conducted the present study on Chinese patients.

Thus far, most clinical studies on the application of NiTi CAR 27 for colorectal anastomosis have been conducted from a single center, including only elective cases from several countries. The collected information of the postoperative complications from partial clinical trials involving nitinol compression devices for colorectal anastomosis between 2011 and 2014 are shown in[Table 4](#t4-cln_71p264){ref-type="table"} [@b21-cln_71p264][@b22-cln_71p264]-[@b23-cln_71p264],[@b17-cln_71p264],[@b24-cln_71p264],[@b14-cln_71p264],[@b25-cln_71p264],[@b15-cln_71p264]. Lee et al. performed a left-sided colon resection with an anastomosis in 79 patients by using NiTi CAR 27. The phase II study showed that only 1 of 79 (1.3%) patients experienced anastomotic leakage after 6 days postoperatively without any clinical symptoms of anastomotic stricture [@b22-cln_71p264]. Another study examining the short-term clinical outcome of a phase II prospective study in 23 patients also demonstrated that NiTi CAR 27 is a promising, safe and effective alternative for the creation of left-side colorectal anastomosis with a low risk of morbidities, including 1 case of abscess (4.3%), 1 case of anastomotic leakage (4.3%) and 2 cases of anastomotic strictures (8.7%) [@b17-cln_71p264]. In addition, the largest data analysis of 1,180 patients who underwent rectal resection with the NiTi ColonRing for an end-to-end anastomosis from 178 centers in 16 countries revealed a promising clinical result, with only a 3.2% (38 patients) overall anastomotic leakage rate [@b14-cln_71p264]. These results suggested that NiTi CAR 27 might be a safe and flexible device for colorectal surgery with a low incidence of postoperative complications.

Compared to stapled anastomosis, the occurrence of general postoperative complications related with anastomosis constructed by the NiTi CAR 27 was not significantly different in our study. Only 2 clinically apparent anastomotic leakages (2.6%) and 1 anastomotic stricture (1.3%) occurred without any anastomotic hemorrhage. As reported in previous clinical studies, anastomotic leakage occurred in 6% to 8% of the individuals with anterior resection by traditional staplers for rectal cancer patients [@b26-cln_71p264][@b27-cln_71p264]-[@b28-cln_71p264]. Our study indicated that the use of NiTi CAR 27 for colorectal anastomosis resulted in a slightly lower risk of anastomotic leakage when compared to a stapled anastomosis (2.6% *versus* 3.2%, *p*=0.804). A similar result was obtained in another study in lower located rectal cancer (within 6 cm from the anal verge) anterior resection by comparison of stapled and compression anastomosis [@b15-cln_71p264]. We observed only 1 patient (1.3%) in the CAR group with anastomotic stricture after anterior resection for rectal cancer at 3 months postoperatively without obvious problems of defecation. Thus far, the cause of anastomotic stricture has not been elucidated. Previous studies have assumed the occurrence of anastomotic stricture was an undetected anastomotic leakage after surgery [@b25-cln_71p264]. We considered inadequate blood supply in the anastomosis to also be a potential cause of anastomotic stricture resulting from the persistent pressure by the compression ring. As previous studies have reported, anastomotic hemorrhage was also reduced by using a compression anastomosis ring for colorectal anastomosis [@b23-cln_71p264],[@b25-cln_71p264],[@b10-cln_71p264]. There was no bleeding at the anastomosis site in the CAR group. The compression ring remains in the body to fix the anastomosis for several days and this sustained pressure forced by the compression ring of the NiTi CAR 27 might play a crucial part in preventing bleeding by compressing the small vessels surrounding the anastomosis. It was assumed that it was beneficial to use the NiTi CAR 27 in patients with a high risk of bleeding. To date, the relationship between the compression device and CRC prognosis has not yet been analyzed [@b29-cln_71p264],[@b25-cln_71p264]. Short-term observations were not sufficient to determine the endpoint of tumor recurrence and progression. Here, we propose the 3-year follow-up survival outcome of the CRC patients who used the NiTi CAR 27. In terms of the comparable 3-year overall survival result between the two groups, we considered that the NiTi CAR 27 obtained a similar long-term survival efficacy for rectal cancer compared with the traditional staplers used for CRC surgery.

There are potential limitations of this study. The first is its retrospective methodology from a single-institution experience. To reduce bias, we only enrolled patients who had the same disease and who underwent the end-to-end anastomosis surgical procedures. Moreover, the limited number of patients in the present study made it difficult to distinguish the slight difference at the level of statistical significance. In addition, the initial treatment for colorectal cancer and the preoperative treatments varied, especially with respect to radiotherapy. These factors, to some extent, influence the occurrence of postoperative complications and long-term survival. However, even with these limitations, the results of our study can be of value for prospective clinical studies in the future.

In conclusion, NiTi CAR 27 is safe and effective for end-to-end anastomosis in colorectal cancer (CRC) surgery with acceptable postoperative complications and shows a similar long-term efficacy in comparison with conventional circular staplers. The use of NiTi CAR 27 is equivalent to that of the conventional circular staplers, suggesting that NiTi CAR 27 might be a beneficial alternative for colorectal anastomosis in Chinese CRC patients.
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![The structure of the NiTi compression anastomosis ring (NiTi CAR 27). It consists of 1. A nitinol mental compression ring, 2. an anvil, 3. a ring loader, and 4. a firing device.](cln-71-05-264-g001){#f1-cln_71p264}

![Abdominal radiographs showing the preliminary healing of anastomotic leakage after 5 days post-operation with the ring (arrow) retained in the anastomosis before the ileostomy takedown.](cln-71-05-264-g002){#f2-cln_71p264}

![One patient experienced anastomosis stricture after 3 months post-operation as determined by an electronic colonoscopy.](cln-71-05-264-g003){#f3-cln_71p264}

![The evacuated NiTi compression anastomosis ring (NiTi CAR 27).](cln-71-05-264-g004){#f4-cln_71p264}

![The electronic colonoscopy view of the smooth anastomosis after 3 months postoperatively.](cln-71-05-264-g005){#f5-cln_71p264}

![The 3-year overall survival (OS) was 83.1% (CAR group) and 89.0% (STA group), *p*=0.152(A). In the stage 0-III patients, the 3-year OS was 94.5% (CAR group) and 98.2% (STA group), *p*=0.205; (B) in the stage IV patients, the 3-year OS was 12.1% (CAR group) and 32.3% (STA group), *p*=0.170 (C).](cln-71-05-264-g006){#f6-cln_71p264}

###### 

Clinical characteristics of the patients in the NiTi CAR 27 and stapler subgroups.

                                     NiTi CAR 27         Stapler             *p* value
  ---------------------------------- ------------------- ------------------- -----------
  Clinical characteristics           (N=77)              (N=157)             
  Gender                                                                     0.868
   Male                              46(59.7%)           92(58.6%)           
   Female                            31(40.3%)           65(41.4%)           
  Median age (year, range)           60(20-77)           59(20-81)           0.885
  Median BMI (kg/m^2^)               22.5(14.6 - 29.9)   22.1(16.4 - 29.7)   0.908
  Comorbidities                                                              
   Hypertension                      18(23.4%)           26(16.6%)           0.210
   Diabetes mellitus                 2(2.6%)             10(6.4%)            0.219
   Obesity                           20(26.0%)           31(19.7%)           0.278
   Severe anemia                     2(2.6%)             0(0)                0.043
   Intestinal obstruction            1(1.3%)             2(1.3%)             0.987
  Preoperative chemoradiotherapy     8(10.4%)            25(15.9%)           0.253
  Tumor site                                                                 0.938
   Sigmoid colon                     32(41.6%)           32(40.8%)           
   Upper rectum (\>5 cm)             41(53.2%)           41(52.9%)           
   Lower rectum (≤5 cm)              4(5.2%)             10(6.4%)            
  Postoperative pathological stage                                           0.491
   Stage 0                           4(5.2%)             7(4.5%)             
   Stage I                           14(18.2%)           21(13.4%)           
   Stage II                          27(35.0%)           51(32.5%)           
   Stage III                         20(26.0%)           56(35.6%)           
   Stage IV                          12(15.6%)           22(14.0%)           

Abbreviations: BMI: body mass index

###### 

Perioperative data of the patients receiving compression and stapled anastomosis.

  Parameter                                         NiTi CAR 27 (N=77)   Stapler (N=157)   *p* value
  ------------------------------------------------- -------------------- ----------------- -----------
  Type of operation                                                                        
   Sigmoidectomy                                    31(40.3%)            64(40.8%)         0.941
   Anterior resection                               46(59.7%)            93(59.2%)         
  Median operation time (min, range)                140(60-370)          150(60-420)       0.720
  Median perioperative blood loss (ml, range)       50(30-1000)          50(20-300)        0.323
  Time to the first flatus (day, range)             3(1-7)               3(2-8)            0.149
  Median postoperative hospital stay (day, range)   8(6-32)              8(5-29)           0.523

###### 

Comparison of the postoperative complications in two types of anastomotic devices.

  Complications            NiTi CAR 27 (N=77)   Stapler (N=157)   *p* value
  ------------------------ -------------------- ----------------- -----------
  Anastomotic leakage      2(2.6%)              5(3.2%)           0.804
  Anastomotic stricture    1(1.3%)              0(0)              0.152
  Intestinal obstruction   3(3.9%)              2(1.3%)           0.192

###### 

Detailed information on the total postoperative complications in the NiTi CAR 27 group.

  Gender   Age   Tumor location   Type of operation     Hospital stay (days)   Complication              Complication detected on POD   Measure of diagnose       Intervention              Outcome
  -------- ----- ---------------- --------------------- ---------------------- ------------------------- ------------------------------ ------------------------- ------------------------- ---------------
  female   20    rectum           Anterior  resection   27                     Intestinal  obstruction   11                             abdominal  X-ray          conservative  treatment   deterioration
  female   46    rectum           Anterior  resection   32                     Anastomoticleakage        4                              clinical  symptoms        Ileostomy                 recovery
  male     65    rectum           Anterior  resection   10                     anastomoticstricture      90                             electronic  colonoscopy   Wait and see              stabilization
  male     74    Sigmoid  colon   Sigmoidectomy         21                     Intestinal obstruction    6                              clinical  symptoms        conservative  treatment   recovery
  male     68    Sigmoid  colon   Sigmoidectomy         25                     Intestinal  obstruction   8                              abdominal  X-ray          Operation                 recovery
  male     61    rectum           Anterior  resection   21                     Anastomoticleakage        5                              abdominal  X-ray          Ileostomy                 recovery

Abbreviations: POD: postoperative day

###### 

Summary of the anastomosis-related postoperative complications that occurred in the patients using the nitinol compression devices.

  Author(References)                    Year   Patients (N)   Median time to first flatus (Day)   Hospital stay (Day)   Anastomotic leakage   Anastomotic hemorrhage   Anastomotic stricture
  ------------------------------------- ------ -------------- ----------------------------------- --------------------- --------------------- ------------------------ -----------------------
  Lee et al. ([@b22-cln_71p264])        2011   79             NR                                  7 (4-29)              1 (1.3%)              0                        0
  Buchberg et al. ([@b17-cln_71p264])   2011   23             4 (2--31)                           5 (3-41)              1 (4.3%)              0                        2 (8.7%)
  Dauser et al. ([@b23-cln_71p264])     2011   62             3 (1-6)                             8 (4-183)             0                     0                        1 (3.3%)
  Koo et al. ([@b21-cln_71p264])        2012   66             NR                                  7 (4-20)              1 (1.5%)              0                        0
  Bernhard et al. ([@b15-cln_71p264])   2013   38             NR                                  11                    2 (5.3%)              0                        0
  Khromov et al. ([@b24-cln_71p264])    2013   40             2.4                                 7.3                   2(5%)                 0                        0
  Masoomi et al. ([@b14-cln_71p264])    2013   1180           NR                                  6 (2-21)              38 (3.2%)             NR                       NR
  Kwag et al. ([@b25-cln_71p264])       2014   63             1.7                                 5.9                   1 (1.6%)              0                        1 (1.6%)
  Present study                         2014   79             3 (1-7)                             8 (6-32)              2 (2.6%)              0                        1 (1.3%)

NR: Not recorded
